Kurtz, JE; Anota, A; Cropet, C; Priou, F; Harter, P; Pignata, S; Palacio, I; Petru, E; Kobayashi, H; Vuylsteke, P; Parma, G; Maenpaa, J; Raymond, E; Buderath, P; Lorusso, D; Herrero, A; Raban, N; Pujade-Lauraine, E; Joly, F; Ray-Coquard, IL.
Quality of life in patients with advanced high-grade ovarian cancer (HGOC) receiving maintenance therapies after first-line (1L) chemotherapy in the randomized phase III PAOLA-1/ENGOT-ov25 trial (NCT02477644).
J CLIN ONCOL. 2022; 40(16):
[Poster]
Web of Science